Bacterial infections have always been, and still are, a major global healthcare problem. For accurate treatment it is of upmost importance that the location(s), severity, type of bacteria, and therapeutic response can be accurately staged. Similar to the recent successes in oncology, tracers specific for molecular imaging of the disease may help advance the patient management. Chemical design and bacterial targeting mechanisms are the basis for the specificity of such tracers. The aim of this review is to provide a comprehensive overview of the molecular imaging tracers developed for optical and nuclear identification of bacteria and bacterial infections. Hereby we envision that such tracers can be used to diagnose infections and aid their clinical management. From these compounds we have set-out to identify promising targeting mechanisms and select the most promising candidates for further development.
Introduction
Since the beginning of the last century antibiotics have been developed and used to treat bacterial infections, e.g. penicillins, quinolones and glycopeptides. Despite the success of these compounds, bacterial infections are still a serious global healthcare problem. Tuberculosis is the most prominent example causing an estimated 1.5 million deaths in 2009 (table 1) . 1 In most patients bacterial infections are only identified when they have reached a systemic stage. Alternatively, the disease can become apparent when it has resulted in anatomical damage evident from clinical symptoms and/or via anatomical imaging e.g. X-ray, computed tomography (CT) and/or magnetic resonance imaging (MRI). 2 We reason that early and molecular diagnosis of bacterial infections has the potential to allow optimization of treatment regimes. A prerequisite for such molecular diagnosis are imaging agents that can specifically accumulate in or around bacteria (scheme 1B). While the applications of molecular imaging are showing success in e.g. oncology, there still is a shortness of effective molecular imaging approaches for bacterial infections. In our view, molecular imaging approaches for bacterial infections have the potential to i) discriminate bacterial infections from sterile inflammation, ii) visualize the anatomical spread of infections, iii) identify the type of bacteria to select the best antimicrobial therapy, and iv) allow therapy monitoring.
Several unique molecular characteristics have been exploited to specifically target bacteria (summarized in scheme 1A). Especially the (negatively charged) bacterial membrane, excreted and membrane bound enzymes and receptors, intracellular enzymes and the DNA synthesis and translational machinery are specifically targeted. Next to this, passive internalization and intracellular entrapment can yield specific accumulation in bacteria. To achieve such targeting, and be suitable for clinical diagnostics, chemical entities have to fulfill a number of requirements. They should: 1) be non-toxic for the host, 2) target bacterial infections or produce a detectable signal upon interaction with bacteria, 3) penetrate rapidly into the infected area, and 4) emit a signal that allows in vivo identification. Table 1 .
Scheme 1.
For the visualization of bacterial infections there are two main routes of tracer administration, namely intravenous (IV) injection or a topical (local) administration. Whole body diagnostics of bacterial infections requires intravenous injection followed by 3D nuclear imaging technologies such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) preferably combined with CT or MRI for anatomical reference. 7 SPECT and PET imaging requires the incorporation of a radiolabel on the chemical moieties used to target the bacteria. Alternatively, superficial identification of bacterial infections and their spread e.g. during the surgical removal of infected prosthetics would benefit from fluorescence based identification. [8] [9] [10] This relatively unexplored approach can be accomplished after IV administration of a fluorescent tracer, but could also benefit from the topical introduction of (activatable) imaging tracers.
The technical aspects of nuclear and optical imaging of non-specific infection/inflammation imaging and the tracers currently used in the clinic have been reviewed by Signore et al, 11 and Dorward et al. 12 Regarding the current clinical state of the art, a number of nuclear imaging tracers are applied for non-invasive visualization of inflammations and infections, being 67 Ga-citrate (the oldest tracer), 13, 14 its PET counterpart 68 Ga-citrate, [15] [16] [17] and a variety of radiolabeled leukocytes.
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Unfortunately these tracers accumulate in areas with sterile inflammations, infections, tissue regeneration, and cancerous lesions, making them non-specific for bacterial imaging.
Here we summarize the most well investigated classes of bacterial tracers, as well as -in our view-high potential bacterial imaging approaches.
Methods:
We performed an extensive literature research to identify bioactive compounds, conjugated to fluorescent or radioactive labels, designed for the imaging of bacterial infections. The identified compounds are classified on their general structure and targeting mechanism. The main families are the zinc(II)-dipicolylamine (Zn-DPA) tracers, the antimicrobial peptides, the antibiotics, the activatable tracers and the proteins. To provide a comprehensive overview of the different imaging tracers described in the literature, the chemical structures of the compounds have been added in the supporting information. The numbering of the compounds in the supporting information has been used in the main review. The reported bacterial specificity and uptake in infected tissues, indicated by the target to non-target (T/NT) ratios of the different compounds (also see the supporting information) were used to compare the different imaging tracers and select the most optimal chemical designs for molecular bacterial imaging strategies.
Most widely studied bacteria specific tracers

Zn-DPA
The negatively charged lipopolysaccharide and carbohydrate residues located in the outer membrane of both gram-positive and gram-negative bacteria are a potential target for imaging tracers.
The positively charged metal complex zinc(II)-dipicolylamine (Zn-DPA) interacts with these negatively charged membranes (scheme 1A). This interaction facilitates discrimination between negatively charged bacterial membranes and neutrally charged membranes of mammalian cells. The
Zn-DPA moiety facilitates conjugation to several types of labels, although the research has mainly focused on fluorescent labels.
Labeling methods
Imaging agents based on dimers, tetramers and multimers of Zn-DPA have been developed. A dimer was conjugated via a short polyethylene glycol spacer (PEG) to dansyl (1) or directly to fluorescent anthracene (2). 25 A near-infrared (NIR) version of this tracer was developed by coupling a NIR-cyanine dye to the Zn-DPA moieties via a short alkyl spacer ( fig. 1B; 3) . This compound (commercialized as PSVue794) demonstrated membrane staining of bacterial cells both in vitro and in murine infection models. [26] [27] [28] A Cy5-labeled Zn-DPA tracer (4) was applied to study the binding to bacterial membranes in more detail via förster resonance energy transfer (FRET) interactions with a fatty acid conjugated Cy3-derivative that was incorporated in a bacterial-like lipid bilayer vesicle.
29
A second generation of the Zn-DPA moiety, based on 2,6-bis(zinc(II)-dipicolylamine)phenoxide (5), was developed by DiVittorio et al. 30 The tyrosine core of this targeting moiety enabled its incorporation in peptides and offered an additional reactive group for the attachment of moieties to fine-tuning the chemical and biological behavior of the synthesized tracers.
Based on this concept, the 7-nitrobenz-2-oxa-1,3-diazol-4-yl-label (NBD) labeled version was synthesized and tested. Unfortunately no comparison was made with the first generation tracers.
To develop Zn-DPA targeted tracers with brighter (higher quantum yield) and more photostable dyes, Johnson et al. selected a squaraine dye. 31 Although squaraine dyes are chemically unstable in biological environments, incorporation into a rotaxane moiety to form a sterical barrier improved their stability dramatically. The squaraine rotaxane, labeled with four Zn-DPA moieties (6), proved to be equally bright to a Cy5-labeled version, but was found to be more photostable (t 1/2 of 1080 s and 11 s respectively). This increased photostability allowed the generation of real-time fluorescence-microscopy movies of dividing bacteria incubated with the imaging tracer. 31 Squaraine dyes, protected by two different rotaxanes (6, 7), allowed in vivo visualization of infections.
32
The Zn-DPA targeting moiety has also been applied on nanoparticles presenting multiple copies of the targeting moiety. Biotin conjugated to Zn-DPA (8) facilitated binding to streptavidin coated quantum dots ( em 565, 655 and 800 nm). 33 A radioactive imaging agent containing the Zn-DPA targeting moiety has also been developed. Herefore, biotinylated Zn-DPA and biotinylated
111
In-DOTA (9) were combined on streptavidin in a 1:1:1 ratio.
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Bacterial imaging studies
From a chemical point of view, the targeting moieties of the above-described tracers are exactly the same, except for compound 5. This offers the opportunity to compare the effect of the different imaging labels on the biological performance of the tracers. All compounds, except for the Zn-DPA labeled quantum dots (8) were able to bind to both gram-positive and gram-negative bacteria in vitro and in vivo. The quantum dots showed selectivity for gram-negative bacteria because their relatively large size (15-20 nm) prevented them from passing through the cell wall of gram-positive bacteria thereby limiting the interactions with the negatively charged membrane.
33
For compounds 3, 4, 6 and 7, the T/NT ratio in vivo was measured at several time points after IV injection. Thakur et al. reported a maximum T/NT ratio of 6.6 for a bacterial infection in the thigh of mice and a T/NT = 3.2 for a sterile inflammation at 3 h post injection of compound 3 (Fig. 1A) .
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Cy5-labeled Zn-DPA derivative 4 showed the fastest clearance and reached a T/NT ratio of 4.2 (6 h post injection); Little residual fluorescence was present at 24 h post injection. 29 A clear difference in bacterial imaging was seen between the lipophilic squaraine rotaxane 7 and the more hydrophilic squaraine rotaxane 6. Tracer 6 reached a T/NT ratio of 6 (6 h post injection) and this ratio decreased to 4 (21 h post injection), while the accumulation of 7 steadily increased to a T/NT ratio of 4 (12 h post injection) and remained steady till 21 h post injection. 32 The non-specific uptake in various organs was also significantly higher for the more lipophilic compound 7. The radiolabeled Zn-
In-DOTA-biotin-streptavidin complex reached a T/NT ratio of 2.8 (22 h post injection).
Although the usefulness of the Zn-DPA targeting moiety for bacterial imaging has been demonstrated in several studies, its affinity for negatively charged structures has also been applied to target apoptotic cells, which become more negatively charged during the onset of apoptotic and necrotic processes. [35] [36] [37] [38] [39] [40] In this respect, also necrotic processes related to tumors have been imaged
with Zn-DPA targeting moieties, because tumor genesis often involves dying cells (T/NT ratio of 2.2 at 24h post injection).
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Figure 1
Summary Promising results have been described with the widely studied fluorescently and radioactive labeled Zn-DPA-derivatives. Both in vitro and in vivo, they have been able to label bacteria and image bacterial infections. However, the specificity remains an issue. Zn-DPA targets negatively charged cells, so this moiety targets also dead and dying cells such as in apoptotic and necrotic processes, which appear in both infectious and inflammatory processes. For that reason we think that Zn-DPA-derivatives are not the best candidates for infection specific imaging.
Antimicrobial peptides
Antimicrobial peptides (AMPs) are short polypeptides (12-50 residues) that form a part of the innate immune system in all classes of life. Generally, these antimicrobial peptides form amphipathic helices that bind to the bacterial membrane, mostly based on electrostatic interactions, and damage its integrity (scheme 1A). These peptides demonstrate a broad-spectrum activity against both grampositive and gram-negative bacterial strains. The interaction of these compounds with bacterial membranes makes them promising tools for targeting bacterial infections.
Labeling methods
Few fluorescently labeled AMPs have been described in the literature and they have not yet been applied broadly for infection imaging. Fluorescein-labeled Buforin II (10) and magainin 2 (11)
were synthesized via an isothiocyanate coupling. The exact position of the label was not specified by the authors, as multiple free amines (N-terminus and lysine residues) were available for reaction with the isothiocyanate. Fluorescence imaging of labeled bacteria revealed internalization of Buforin II, while magainin 2 remained extracellular and caused lysis of the bacterial membrane.
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Cy5-labeled antimicrobial peptides cecropin P1 (12), SMAP29 (13) and PGQ (14) were synthesized by the selective introduction of a Cy5-maleimide on C-terminal cysteine residues, which left the pharmacophore of the AMP intact. These fluorescently labeled AMPs were applied for the direct labeling of bacteria or to replace antibodies in an in vitro immuno-magnetic bead biosensor.
43
Bac7 1-35 (15), labeled with bodipy-maleimide on a C-terminal cysteine residue, was used to evaluate bacterial penetration in vitro using fluorescence-activated cell sorting (FACS).
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Furthermore, Bac7 1-35 was labeled with Alexa680-maleimide and studied for its antibacterial action in vivo. The distribution in healthy mice was studied by quantifying the fluorescence signal, but no targeting experiments in infected mice were conducted. Tc-UBI 29-41 T/NT ratios between 2-3.5
(1-2 h post injection) were reported in mice with an infected thigh muscle.. 48, 64 In rabbits with infected thigh muscles, T/NT ratios between 2-5 (1-4 h post injection) were reported. 83 However, the value of these constructs for in vivo application is limited due to their large size.
Smaller analogues ranging from 1-7 monosaccharides have also been applied for bacterial imaging (27-36). Trehalose is a non-mammalian disaccharide that is incorporated in the membrane of mycobacteria by the trehalose mycolyltransesterase enzymes (Ag85 A-C). 
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Bacterial imaging studies Moreover, a T/NT ratio of 2 was still achieved in mice infected with 10 5 CFU, indicating a high sensitivity. Uptake was shown in all tested strains: E. coli, P. aeruginosa, B. subtilis and S. aureus, which could make compound 27 a versatile tracer. Tc-HPCD was mainly cleared via the kidneys. In patients it showed an increased uptake in an infected knee over a control knee. Unfortunately, no T/NT ratios were reported and very poor information was provided in this publication about the used compounds and performed studies, which made it hard to draw any conclusions regarding its usefulness in infection imaging. 
Antibiotics
The largest group of targeting moieties that has been investigated for infection imaging are the antibiotics. These drugs interact with high affinity and specificity with bacterial structures and intracellular proteins and enzymes (scheme 1A). It is this specificity that theoretically makes them ideal targeting moieties. Various studies have been performed using radiolabeled or fluorescently labeled antibiotics.
Labeling methods
Until now, most fluorescently labeled antibiotics have been used to study the permeability of Radioactive labeling is, generally speaking, a better choice for in vivo imaging applications with the relatively small sized antibiotics. Compared to labeling with large optical imaging labels, there is little to no effect of the nuclear labeling on the chemical structure. 
Pretargeting
Vancomycin has been applied in a pretargeting approach. The antibiotic was labeled with a trans-cyclooctene via the free amine on the carbohydrate moiety (41). After binding to bacteria, a magnetofluorescent nanoparticle (MFNP) with a tetrazine-moiety was added. This resulted in a reaction with the cyclooctene-vancomycine via the tetrazine-trans-cyclooctene ligation (TTCO) and subsequent visualization of the bacteria. 151 A similar experimental setup was carried out with daptomycin, although this was less successful due to poor binding and/or due to diminished reactivity towards the tetrazine conjugated MFNPs.
Bacterial imaging studies
Although many antibiotics have been radiolabeled and tested for infection imaging applications, most of them were not successful in doing so. Modest to low T/NT ratios were reported or similar T/NT ratios were observed for both bacterial infections and sterile inflammations, indicating that no discrimination could be made.
There are however some promising candidates within this class of imaging tracers, which we shortly discuss below. compared to 4 and 3.3 respectively was reported. 131 High T/NT ratio of 7.3 for an MRSA infection and 1.2 for a sterile inflammation (90 min post injection) were obtained in rats with Tc-rifampicin (72). 137 The plant-derived 99m
Tc-pheophorbide-a (73) was able to discriminate between an infected and inflamed thigh muscle in rats with a T/NT ratio of 5.6 compared to 1.3 respectively (1 h post injection). 138 However, the amount of accumulated dose of the tracers was very low (0.0017 %ID/g).
Injection of 99m
Tc-vancomycin (38) resulted in a T/NT ratio of 5 in S. aureus infected rats compared to a ratio of 1.5 for a sterile inflammation (1 h post injection).
99m
Tc-Isoniazid (76) showed a T/NT ratio of 3.5 (24 h post-injection) and could discriminate between an S. aureus and an M. tuberculosis infection. 145 The combination of a 24 h imaging interval and the short half-life of 99m Tc (6h) required a high initial dose to obtain sufficient signal. The for an S. aureus inflamed muscle in rats and a 14.9 ratio for a turpentine oil induced sterile inflammation. 143 However, no further studies were performed or imaging data were presented.
Figure 6.
The most extensively studied radiolabeled antibiotic is ciprofloxacin, of which the antibiotic could detect bacterial infections in both animal models and patients. [152] [153] [154] [155] [156] [157] [158] However, also critical results have been reported; e.g. significant accumulation in noninfected prosthetic joints and the inability to discriminate between infected and aseptic osteoarticular disease in patients. 116, [159] [160] [161] In a phase II clinical study Infecton® showed poor specificity and accuracy in patients with suspected osteomyelitis both at images taken 2 h and 24 h post injection. 
Labeling methods
Genetically labeled bacteriophages were created by incorporation of green fluorescent protein (GFP) on the C-or N-terminus of the small outer capsid (SOC) proteins of the virus to image bacteria e.g. in sewage water. 169, 170 Bacteriophages have been fluorescently labeled with fluorescent nucleic acid dyes SYBR gold and SYBR green I, after which they were used to target and label bacteria. 171, 172 By combining immuno-magnetic isolation by antibody-coated magnetic beads with staining by bacteriophages, Goodridge et al. could reach very low detection limits (10 1 -10 2 CFU/mL) of bacterial pathogens in food samples. 173 The success of this approach strongly depended on the specificity of the applied antibodies and bacteriophages. 
Bacterial imaging studies
Until now, none of these fluorescently labeled bacteriophages have been used for imaging bacterial infections in vivo, only for detecting bacteria in food or water samples.
With the radiolabeled bacteriophage M13 a higher accumulation was observed in an E. coli infected thigh muscle compared to an inflamed thigh. 174 T/NT ratios of 2-2.5 for infected and 1.5-1.8
for inflamed tissues were reported (3 h post injection). Although the differences in uptake between an inflammation and an infection were significant, it was difficult to discriminate between them when evaluating the scintigrams. The authors expanded their approach for imaging infections with other 99m
Tc-labeled bacteriophages, such as P22, E79, VD-13 and 60. 175 Moderate to high in vivo T/NT ratios (2.1-14.2) were reported for infections with their target bacteria. However, for all imaging studies with all bacteriophages high liver uptake was observed.
Summary
The strength and at the same time the limitation of bacteriophages is that they only have affinity for specific bacterial strains, which would make it necessary to develop multiple bacteriophages for each bacterial strain of interest. A broad spectrum bacteriophage or a library of bacteriophages directed against multiple bacterial strains would be more widely applicable and would make this class of tracers into a high potential approach. 
Quorum-sensing
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Bacterial imaging studies B. cenocepacia is a pathogen that infects mainly patients suffering from cystic fibrosis or with an compromised immunity. This bacterium was successfully labeled by FLAQS in vitro, both in an isolated sample as in a mix of CepR-expressing and CepR-knockout bacteria. 178 No labeling was observed of bacterial strains that do not express the CepR receptor.
Summary
Although a very new field of bacterial imaging, targeting the bacteria via their communication system is a very elegant and promising approach. Each bacterial strain will have their own language (different set of compounds) which can be used as target.
Enzyme activated tracers
The enzymatically activatable tracers are a very interesting class of fluorescent tracers that utilize an approach that is already successfully applied in the field of oncology. These fluorescently silent tracers regain their fluorescence upon cleavage by bacterial proteolytic enzymes (scheme 1A).
There 
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Bacterial imaging with β-lactamase-sensitive tracers was introduced by Kong et al. They applied a Cy5.5 dye and a quencher (QSY21-derivative) linked via a -lactam linker ( fig. 7B; 83, 84 ).
In vitro a 10-fold increase in fluorescence was detected upon cleavage of this linker by -lactamase.
This tracer was able to identify 10 4 viable CFU M. tuberculosis in lungs of infected mice via fluorescence imaging (Fig. 7A) . 182, 183 Infected macrophages could also be analyzed by fluorescenceactivated cell sorting (FACS). Response monitoring to antibiotic treatment was also performed and visualized with this tracer, both in vitro and in vivo. nm; 91) and with dabcyl/edans (350/495nm; 92). [190] [191] [192] [193] [194] Infection imaging based on the activity of sortase has not been performed yet.
Pretargeting with sortase
By introducing reactive moieties on gram-positive bacteria by sortase a pretargeting approach was developed. This approach was first tested by direct labeling with fluorescein (93), which yielded fluorescently labeled bacteria in vitro. 195 Next, an azide moiety was introduced onto the bacterial peptidoglycan layer via sortase. 195 A secondary labeling could then be performed via a copper-free click reaction with Alexa Fluor 488-DIFO (94).
Other activatable compounds
The chromogenic antibacterial compounds based on phenoxazinone have been deactivated by coupling to β-alanine (95). The presence of bacterial β-alanylaminopeptidase can reactivate the chromo-or fluorophore yielding a visible signal. A detection based on a chromophore was first attempted and the tracer visualized different species of bacteria based on the colored read-out. 196 A similar approach was conducted using N-aminoacylnaphthyridines (96). Upon cleavage of the β-alanyl moiety, fluorescence was detected on agar-plates (350/370-440 nm), however, the obtained signals were too low for in vivo applications. 197 Staphylococcal strains produce staphylocoagulase, an enzyme that forms a selective protease together with prothrombin and is able to metabolize fibrinogen into fibrin. In this process it cleaves after the sequence X-Val-Pro-Arg-. This enzymatic action has been exploited to develop activatable fluorescent tracers based on coumarin to visualize staphylococcal strains. 198, 199 The sensitivity of these probes was improved by making a rhodamine version of these activatable probes (97), which has been applied in in vitro screenings. 200 
Summary
Enzyme activatable infection tracers hold great promise and deserve much more attention in our view. Especially the low background signal, until these tracers are activated by bacteria, makes this class of imaging tracers ideal for local and topical applications. The main challenges for the further development of activatable tracers are achieving specificity for bacterial enzymes and generating a strong enough signal to facilitate in vivo imaging.
Proteins
In addition to the above, a number of proteins have also been reported.
The protein-based class of bacterial imaging tracers consists mainly of endogenous proteins that are required by the bacteria, either for their own virulence or as a source of crucial nutrients and growth factors (scheme 1A). These proteins can be converted into imaging tracers by conjugating them with a suitable label. We here only mention the most promising candidate prothrombin; the other candidates are listed in the SI.
Prothrombin
Staphylococcal strains are capable of secreting a fibrinogen-binding protein (staphylocoagulase). Prothrombin binds to staphylocoagulase to form an active complex that has fibrinogen-clotting capabilities, which in turn acts as a virulence factor in the infection pathogenesis. 201 Labeled prothrombin has been used to image S. aureus in endocarditis. The labeling of prothrombin was performed via a small inhibitory peptide that binds covalently in the active site of prothrombin ( fig. 8B ). Next, a thiol group located in this small inhibitory peptide was deprotected and subsequently labeled with Alexa680-maleimide or 
Summary
The class of protein-based bacterial tracers is quite diverse and their specificity is still under debate. Due to their medium to large molecular size their targeting of infections will most likely be based on both non-specific accumulation and specific targeting.
Discussion
Most tracers we have described in this review were developed with the intention to image bacterial infections. Evidently such tracers hold great medical potential if they: i) lead to clinical detection of infections, ii) enable discrimination between sterile inflammations and bacterial infections, and iii) allow for therapy response monitoring. Although the majority of the bacterial tracers still rely on rather generic targeting moieties, we are under the impression that, similar to e.g.
cancer diagnostics, the field of bacterial imaging is moving towards more biomarker specific approaches. This can mean specific targeting of membranous biomarkers or the use of specific enzymatic activation pathways.
A major hurdle in the development of infection specific imaging agents is the selectivity for infections over inflammatory processes. Although the in this review described imaging tracers are developed to target bacteria specifically, many of them could not fulfill that expectation. Since good comparative studies are lacking it is difficult to support one approach over the other. Nevertheless, we defined "potential" in four categories: 1) tracers that are well investigated and where first-in-human data is available, 2) tracers that will be relatively easily introduced in the clinic, 3) promising tracers that utilize a concept proven in other imaging approaches, 4) innovative new concepts.
Three tracers from the well-studied tracer families belong in category 1: membranes. 203 The concept of enzymatically activatable tracers has already been successfully applied in the field of oncology and the concept will -in our view-also be very well applicable in the field of infection imaging. 204 Category 4 includes the application of bacteriophages and targeting quorum sensing. These approaches have a high potential through their selectivity for individual classes of bacteria. However more exploratory research is required in these areas.
In this review we have focused on two imaging modalities, being nuclear imaging and fluorescence imaging. Each of these modalities has its own strengths and weaknesses. Nuclear imaging is ideal for detecting hidden and deep seeded infections. Due to its high tissue penetration it allows non-invasive whole body scanning. This said, nuclear imaging has a low spatial resolution and real-time surgical imaging is difficult. Fluorescence imaging has a high spatial resolution and can be visualized in real-time by dedicated fluorescence camera systems, thus allowing for a surgical use. 205, 206 Unfortunately, optical imaging suffers from poor tissue penetration, even for dyes in the favorable near infrared window, the tissue penetration is limited to approximately one centimeter. 
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